CUL4A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.594400E-01
Normal-vs-Stage2
5.803600E-01
Normal-vs-Stage3
3.859400E-01
Normal-vs-Stage4
4.264600E-01
Stage1-vs-Stage2
6.502600E-01
Stage1-vs-Stage3
5.216200E-02
Stage1-vs-Stage4
7.464600E-01
Stage2-vs-Stage3
7.453500E-02
Stage2-vs-Stage4
9.070000E-01
Stage3-vs-Stage4
1.316640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.107200E-01
Normal-vs-AfricanAmerican
6.799400E-01
Normal-vs-Asian
7.786000E-01
Caucasian-vs-AfricanAmerican
9.663600E-01
Caucasian-vs-Asian
6.187600E-01
AfricanAmerican-vs-Asian
7.640200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.573000E-01
Normal-vs-Female
6.739400E-01
Male-vs-Female
3.972400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.115600E-01
Normal-vs-Age(41-60Yrs)
4.669800E-01
Normal-vs-Age(61-80Yrs)
7.014200E-01
Normal-vs-Age(81-100Yrs)
4.078000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.539200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.563400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.813200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.275000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.773200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.296400E-01
Normal-vs-Daily Drinker
9.974200E-01
Normal-vs-Weekly Drinker
7.127800E-01
Normal-vs-Occasional Drinker
1.878450E-01
Normal-vs-Social Drinker
3.560800E-01
Non Drinker-vs-Daily Drinker
8.527400E-01
Non Drinker-vs-Weekly Drinker
5.801400E-01
Non Drinker-vs-Occasional Drinker
2.665700E-02
Non Drinker-vs-Social Drinker
2.357800E-01
Daily Drinker-vs-Weekly Drinker
4.819400E-01
Daily Drinker-vs-Occasional Drinker
1.733560E-02
Daily Drinker-vs-Social Drinker
1.610780E-01
Weekly Drinker-vs-Occasional Drinker
1.743790E-01
Weekly Drinker-vs-Social Drinker
6.218400E-01
Occasional Drinker-vs-Social Drinker
2.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.498500E-02
Normal-vs-Grade 2
1.481110E-03
Normal-vs-Grade 3
2.900200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.621000E-01
Grade 1-vs-Grade 3
7.985900E-02
Grade 1-vs-Grade 4
3.498500E-02
Grade 2-vs-Grade 3
9.816400E-02
Grade 2-vs-Grade 4
1.481110E-03
Grade 3-vs-Grade 4
2.900200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.021400E-01
Normal-vs-NonDiabetic
5.274000E-01
Diabetic-vs-NonDiabetic
1.505160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.243800E-01
Normal-vs-NoPancreatitis
6.470800E-01
Pancreatitis-vs-NoPancreatitis
8.403200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.331600E-01
Normal-vs-N1
6.384000E-01
N0-vs-N1
6.379800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.975750E-01
Normal-vs-TP53-NonMutant
8.242800E-01
TP53-Mutant-vs-TP53-NonMutant
6.046100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
